Kornitzer Capital Management Inc. KS Decreases Stake in Xylem Inc. (XYL)

Kornitzer Capital Management Inc. KS lowered its position in Xylem Inc. (NYSE:XYL) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,535 shares of the company’s stock after selling 75 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Xylem were worth $2,301,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Adage Capital Partners GP L.L.C. raised its position in shares of Xylem by 362.8% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,240,920 shares of the company’s stock worth $50,754,000 after buying an additional 972,803 shares during the last quarter. Renaissance Technologies LLC purchased a new position in shares of Xylem during the first quarter worth approximately $35,673,000. American Century Companies Inc. raised its position in shares of Xylem by 190.6% in the second quarter. American Century Companies Inc. now owns 1,161,281 shares of the company’s stock worth $51,851,000 after buying an additional 761,695 shares during the last quarter. PGGM Investments raised its position in shares of Xylem by 219.1% in the second quarter. PGGM Investments now owns 961,686 shares of the company’s stock worth $42,939,000 after buying an additional 660,294 shares during the last quarter. Finally, BlackRock Institutional Trust Company N.A. raised its position in shares of Xylem by 8.6% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 5,296,799 shares of the company’s stock worth $216,639,000 after buying an additional 417,259 shares during the last quarter. Institutional investors and hedge funds own 84.66% of the company’s stock.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Xylem Inc. (NYSE:XYL) traded up 0.65% during mid-day trading on Wednesday, hitting $49.47. The company’s stock had a trading volume of 806,610 shares. The firm has a market cap of $8.86 billion, a price-to-earnings ratio of 26.41 and a beta of 1.15. Xylem Inc. has a 52-week low of $31.67 and a 52-week high of $53.25. The firm has a 50 day moving average of $50.80 and a 200-day moving average of $46.66.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.01. The company earned $932 million during the quarter, compared to the consensus estimate of $927.69 million. Xylem had a net margin of 9.22% and a return on equity of 16.41%. The company’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.43 earnings per share. On average, equities research analysts expect that Xylem Inc. will post $2.04 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 7th. Stockholders of record on Wednesday, November 9th will be issued a dividend of $0.1549 per share. The ex-dividend date is Monday, November 7th. This represents a $0.62 annualized dividend and a dividend yield of 1.25%. Xylem’s dividend payout ratio (DPR) is presently 33.16%.

XYL has been the topic of a number of recent research reports. Atlantic Securities upgraded Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective on the stock in a research report on Monday, August 22nd. Royal Bank Of Canada raised their price target on Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 16th. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Canaccord Genuity restated a “hold” rating and issued a $50.00 price target (up from $45.00) on shares of Xylem in a research report on Tuesday, August 16th. Finally, Barclays PLC raised their price target on Xylem from $39.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Monday, July 18th. Nine research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Xylem currently has an average rating of “Hold” and an average price target of $45.00.

In related news, Director Steven R. Loranger sold 32,246 shares of the business’s stock in a transaction on Thursday, July 28th. The shares were sold at an average price of $48.01, for a total value of $1,548,130.46. Following the sale, the director now owns 38,334 shares of the company’s stock, valued at $1,840,415.34. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Colin R. Sabol sold 27,473 shares of the business’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the completion of the sale, the insider now directly owns 65,530 shares in the company, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.

About Xylem

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Eli Lilly Alzheimer’s Drug Does Not Pass the Test


 
© 2006-2016 Ticker Report. Google+.